The goal of the proposed research is to understand how receptors for neurotransmitter function, and how cells control receptor function. Acetylcholine receptors or mammalian clonal muscle cells in vitro will be studied by biophysical methods, in particular patch clamp, to generate a kinetic scheme which describes receptor activation. The data will be analysed to obtain rate constants for steps in that scheme. The importance of membrane/receptor interactions will be examined by growing the cells in conditions which alter membrane lipid composition. The function of receptors will be analysed and any alterations interpreted in terms of the kinetic scheme for receptor activation. Further experiments will examine the effects of chemical treatments on receptor function, to gain insight into the structure-activity relationship for the acetylcholine receptor. The observation that the function of receptors on these cells changes with time in culture will be exploited to examine the mechanisms by which cells control the function of the receptors which they express. Additional experiments will analyse the function of acetylcholine receptors on developing and adult mammalian skeletal muscle fibers. The data will be used to determine the number of functionally distinct classes of acetycholine receptors expressed by muscle fibers in different conditions. The data will be analysed to determine the appropriate kinetic scheme to describe receptor activation and estimates for rate constants in that scheme will be obtained. The information provided will give insight into the choices the cell has in changing the function of its receptors and the mechanism it uses to control receptor function. The results of these studies are required to form a quantitative picture of the function of receptors for acetylcholine and to determine how the cell controls the function of receptors. Such a picture is necessary to understand the mechanism of synaptic transmission at the neuromuscular junction and to uderstand the mode of action of pharmacological agents. It is also required before changes in synaptic function during development or after pathological processes can be evaluated. In more general terms, the insight gained are applicable to other chemically transmitting synapses and to the overall question of the control of the ionic permeability of biological membranes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS022356-02
Application #
3404604
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1984-12-01
Project End
1987-11-30
Budget Start
1985-12-01
Budget End
1986-11-30
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Washington University
Department
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Jin, Xiaochun; Germann, Allison L; Shin, Daniel J et al. (2017) Determination of the Residues in the Extracellular Domain of the Nicotinic ? Subunit Required for the Actions of Physostigmine on Neuronal Nicotinic Receptors. Mol Pharmacol 92:318-326
Jin, Xiaochun; McCollum, Megan M; Germann, Allison L et al. (2017) The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic ?4?2 Receptors. Mol Pharmacol 91:100-109
Bracamontes, John R; Akk, Gustav; Steinbach, Joe Henry (2016) Introduced Amino Terminal Epitopes Can Reduce Surface Expression of Neuronal Nicotinic Receptors. PLoS One 11:e0151071
Jin, Xiaochun; Steinbach, Joe Henry (2015) Potentiation of Neuronal Nicotinic Receptors by 17?-Estradiol: Roles of the Carboxy-Terminal and the Amino-Terminal Extracellular Domains. PLoS One 10:e0144631
Haller, Gabe; Li, Ping; Esch, Caroline et al. (2014) Functional characterization improves associations between rare non-synonymous variants in CHRNB4 and smoking behavior. PLoS One 9:e96753
Jin, Xiaochun; Bermudez, Isabel; Steinbach, Joe Henry (2014) The nicotinic ?5 subunit can replace either an acetylcholine-binding or nonbinding subunit in the ?4?2* neuronal nicotinic receptor. Mol Pharmacol 85:11-7
Akk, Gustav; Eaton, Megan; Li, Ping et al. (2013) Energetic contributions to channel gating of residues in the muscle nicotinic receptor ?1 subunit. PLoS One 8:e78539
Haller, Gabe; Druley, Todd; Vallania, Francesco L et al. (2012) Rare missense variants in CHRNB4 are associated with reduced risk of nicotine dependence. Hum Mol Genet 21:647-55
Tammimäki, Anne; Herder, Penelope; Li, Ping et al. (2012) Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by ?3?4?5 nicotinic acetylcholine receptors. Neuropharmacology 63:1002-11
Hinrichs, Anthony L; Murphy, Sharon E; Wang, Jen C et al. (2011) Common polymorphisms in FMO1 are associated with nicotine dependence. Pharmacogenet Genomics 21:397-402

Showing the most recent 10 out of 54 publications